Validation of Next Generation Sequencing Technologies in Comparison to Current Diagnostic Gold Standards for BRAF, EGFR and KRAS Mutational Analysis

Next Generation Sequencing (NGS) has the potential of becoming an important tool in clinical diagnosis and therapeutic decision-making in oncology owing to its enhanced sensitivity in DNA mutation detection, fast-turnaround of samples in comparison to current gold standard methods and the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: McCourt, Clare M., McArt, Darragh G., Mills, Ken, Catherwood, Mark A., Maxwell, Perry, Waugh, David J., Hamilton, Peter, O'Sullivan, Joe M., Salto-Tellez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724913/
https://www.ncbi.nlm.nih.gov/pubmed/23922754
http://dx.doi.org/10.1371/journal.pone.0069604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724913/
https://www.ncbi.nlm.nih.gov/pubmed/23922754
http://dx.doi.org/10.1371/journal.pone.0069604

Ejemplares similares